Global Bio-chem Technology Group Co. Ltd. (HK:0809)
:0809
Want to see HK:0809 full AI Analyst Report?
0809 Stock Chart & Stats
HK$0.06
>-HK$0.01(-1.00%)
At close: 4:00 PM EST
HK$0.06
>-HK$0.01(-1.00%)
Day’s Range― - ―
52-Week RangeHK$0.06 - HK$0.12
Previous CloseN/A
Volume370.00K
Average Volume (3M)8.43M
Market Cap
HK$1.01B
Enterprise ValueHK$2.23B
Total Cash (Recent Filing)HK$94.44M
Total Debt (Recent Filing)HK$1.79B
Price to Earnings (P/E)17.6
Beta-0.15
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding16,832,771,000
10 Day Avg. Volume3,078,640
30 Day Avg. Volume8,433,551
Financial Highlights & Ratios
PEG Ratio-0.13
Price to Book (P/B)-3.27
Price to Sales (P/S)0.74
P/FCF Ratio-59.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Stable Structural Demand (amino Acids For Animal Nutrition)Lysine and other feed amino acids are staple inputs for animal nutrition with steady global demand. Exposure to essential feed additives supports baseline volume demand and predictable end-market need over months, helping stabilize core revenue even amid cyclical swings.
Historical Revenue GrowthA multi-year positive revenue growth rate (~13.9%) indicates the company has generated top-line expansion over time, pointing to market traction and product adoption. Sustained revenue expansion provides a foundation for operational scaling if margins and utilization improve.
Diversified Corn-derived Product Portfolio And Manufacturing CapabilityIntegrated manufacturing across amino acids, food additives and corn co-products creates multiple revenue streams and potential cost synergies. Vertical processing capability and product diversity can protect overall revenue if one product faces pricing pressure, supporting medium-term resilience.
Bears Say
Negative Shareholders' Equity And High LeveragePersistently negative equity and large outstanding debt materially weaken financial flexibility. This structural leverage raises refinancing and solvency risk, limits ability to fund capex or weather input shocks, and constrains strategic optionality over the coming months.
Weak, Inconsistent Cash GenerationNegative and volatile operating and free cash flow undermine the firm's ability to service debt, invest in maintenance or growth, and self-fund working capital. Over 2–6 months this elevates dependence on external financing and increases execution risk for operational improvements.
Thin Gross Margins And Negative EBITSlim gross margins leave limited buffer against commodity and energy cost swings, and consecutive negative EBIT shows core operations are loss-making. Coupled with a large 2025 revenue decline, this heightens uncertainty about sustainable profitability and recovery timelines.
Global Bio-chem Technology Group Co. Ltd. News
0809 FAQ
What was Global Bio-chem Technology Group Co. Ltd.’s price range in the past 12 months?
Global Bio-chem Technology Group Co. Ltd. lowest stock price was HK$0.06 and its highest was HK$0.12 in the past 12 months.
What is Global Bio-chem Technology Group Co. Ltd.’s market cap?
Global Bio-chem Technology Group Co. Ltd.’s market cap is HK$1.01B.
When is Global Bio-chem Technology Group Co. Ltd.’s upcoming earnings report date?
Global Bio-chem Technology Group Co. Ltd.’s upcoming earnings report date is Aug 27, 2026 which is in 78 days.
How were Global Bio-chem Technology Group Co. Ltd.’s earnings last quarter?
Global Bio-chem Technology Group Co. Ltd. released its earnings results on Mar 27, 2026. The company reported HK$0.032 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.032.
Is Global Bio-chem Technology Group Co. Ltd. overvalued?
According to Wall Street analysts Global Bio-chem Technology Group Co. Ltd.’s price is currently Overvalued.
Does Global Bio-chem Technology Group Co. Ltd. pay dividends?
Global Bio-chem Technology Group Co. Ltd. pays a Semiannually dividend of HK$0.02 which represents an annual dividend yield of N/A. See more information on Global Bio-chem Technology Group Co. Ltd. dividends here
What is Global Bio-chem Technology Group Co. Ltd.’s EPS estimate?
Global Bio-chem Technology Group Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global Bio-chem Technology Group Co. Ltd. have?
Global Bio-chem Technology Group Co. Ltd. has 16,832,771,000 shares outstanding.
What happened to Global Bio-chem Technology Group Co. Ltd.’s price movement after its last earnings report?
Global Bio-chem Technology Group Co. Ltd. reported an EPS of HK$0.032 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.667%.
Which hedge fund is a major shareholder of Global Bio-chem Technology Group Co. Ltd.?
Currently, no hedge funds are holding shares in HK:0809
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Global Bio-chem Technology Group Co. Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.23%
12-Months-Change
Fundamentals
Return on Equity
-11.47%
Trailing 12-Months
Asset Growth
1.69%
Trailing 12-Months
Company Description
Global Bio-chem Technology Group Co. Ltd.
Global Bio-chem Technology Group Company Limited, an investment holding enterprise, is engaged in the global production and distribution of both refined corn products and biochemicals derived from corn. Its market reach extends across the People's Republic of China, other Asian countries, the Americas, and international territories. The group's operations are divided into four main divisions: Upstream Products, Amino Acids, Corn Sweeteners, and Polyol Chemicals. The company's diverse product portfolio includes a range of corn-refined items such as corn oil, corn steep liquor, corn starch, waxy corn starch, corn gluten meal, feed pellets, and corn germ cake. Furthermore, it offers a variety of downstream corn-based biochemicals, encompassing amino acids like lysine, protein lysine, threonine, and glutamic acid. Its corn sweeteners segment includes high fructose corn syrup, maltodextrin, high maltose syrup, maltose syrup, sorbitol, glucose, and crystallized glucose. Additionally, the firm manufactures modified starches and various chemicals, such as ethylene, propylene, butylene glycols, and resins. Complementing these, the company also supplies anti-freeze solutions, hydrogen, and ammonia. These products serve a multitude of applications across numerous industries, including animal feed manufacturing, food and beverage production, cosmetics, textiles, pharmaceuticals, and the broader chemical sector. Established in 1994, the company's headquarters are situated in Hung Hom, Hong Kong.
Technical Analysis
TS Wonders Holding Limited
―
Zhengwei Group Holdings Company Limited
―
Vedan International (Holdings) Ltd.
―
China Starch Holdings Limited
―
Shenguan Holdings (Group) Limited
―
Options Prices
Currently, No data available
---